Page 1 of Clinical Trials for Allergy Therapeutics [SPONSOR-COLLABORATORS], 21 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
2
Completed
Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
3
Completed
Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
4
Completed
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
5
Completed
Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
6
Completed
Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
7
Completed
Efficacy and Safety/Tolerability of Grass MATA MPL
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
8
Completed
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
9
Completed
Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
10
Withdrawn
Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
11
Completed
Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
12
Completed
Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
13
Suspended
Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
14
Completed
Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
15
Completed
Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
16
Completed
Efficacy and Safety/Tolerability of Ragweed MATA MPL
Last Updated: June 16, 2010
Condition(s): Type I Hypersensitivity
17
Completed
Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
Last Updated: June 9, 2010
Condition(s): Type I Hypersensitivity
18
Terminated
Study to Evaluate the Safety of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy
Last Updated: July 12, 2011
Condition(s): Cat Allergy
19
Active, not recruiting
Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
Last Updated: August 16, 2011
Condition(s): Food Hypersensitivity; Hypersensitivity; Immediate Hypersensitivity; Peanut Hypersensitivity
20
Completed
Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections
Last Updated: December 29, 2006
Condition(s): IgG Deficiency; Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Allergy+Therapeutics

Page 1 of Clinical Trials for Allergy Therapeutics [SPONSOR-COLLABORATORS], 21 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About